Alpha-Gal Syndrome: Recognition, Testing, and Management in the Hospital Setting - On Demand

This CE program will provide healthcare professionals with a practical understanding of alpha-gal syndrome and its implications for medication and healthcare product safety. Participants will learn to identify excipients, medications, biologics, devices, blood products, and surgical materials that may present alpha-gal–related safety concerns; evaluate challenges in assessing risk, including ingredient transparency, product variability, and limitations in available evidence; and apply practical strategies for screening, documentation, communication, and care planning for patients with suspected or confirmed alpha-gal syndrome. The program will also address the clinical and operational implications of alpha-gal syndrome within health systems and across the continuum of care, supporting safer, more informed decision-making and coordination among healthcare team members.

Target Audience

  • Nurses
  • Pharmacists
  • Pharmacy Technicians
  • Other Healthcare Professionals

Learning Objectives

At the conclusion of this activity, participants should be able to:
  • Describe the clinical and operational implications of alpha-gal syndrome within health system practice settings.
  • Identify excipients, medications, biologics, devices, blood products, and surgical materials that may present alpha-gal related safety concerns.
  • Evaluate common challenges associated with determining alpha-gal risk, including ingredient transparency, product variability, and limitations of available evidence.
  • Outline practical approaches for screening, documentation, communication, and care planning for patients with suspected or confirmed alpha-gal syndrome across the continuum of care.
At the conclusion of this activity, pharmacists should be able to:  
  • Describe the clinical and operational implications of alpha-gal syndrome within health system practice settings.
  • Identify excipients, medications, biologics, devices, blood products, and surgical materials that may present alpha-gal related safety concerns.
  • Evaluate common challenges associated with determining alpha-gal risk, including ingredient transparency, product variability, and limitations of available evidence.
  • Outline practical approaches for screening, documentation, communication, and care planning for patients with suspected or confirmed alpha-gal syndrome across the continuum of care.
 
At the conclusion of this activity, pharmacy technicians should be able to:  
  • Describe the clinical and operational implications of alpha-gal syndrome within health system practice settings.
  • Identify excipients, medications, biologics, devices, blood products, and surgical materials that may present alpha-gal related safety concerns.
  • Evaluate common challenges associated with determining alpha-gal risk, including ingredient transparency, product variability, and limitations of available evidence.
  • Outline practical approaches for screening, documentation, communication, and care planning for patients with suspected or confirmed alpha-gal syndrome across the continuum of care.

Course summary

Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 ANCC
  • 0.10 IACET
  • 1.00 Interprofessional Continuing Education (IPCE)
Course opens: 
10/21/2026
Course expires: 
10/20/2027
FACULTY & PLANNERS
Faculty

Zachary Stacy, PharmD, MS, FCCP, BCPS
Clinical Pharmacy Specialist, Surgery
BJC Health

Sandra Lowry, PharmD
Clinical Pharmacist, Center for Medication Policy
Duke University Hospital

Kyna Henrici, RN
Medical Evidence Director, Cardiovascular
Vizient

Planners

Stacy Lauderdale, PharmD, BCPS
Associate Vice President of Evidence-Based Medicine and Drug Information
Vizient, Inc.

Jackie Stokes, BBA
Pharmacy Services Manager
Vizient

Carolyn Liptak, MBA, BS Pharm
Pharmacy Executive Director, Regulatory Compliance & Revenue Integrity
Vizient

Samantha Gordon, MS
CE Programs Manager      
Vizient

Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education       
Vizient

 
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 

Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

 
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.”
 
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity.”
 
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
 
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
All relevant financial relationships listed for these individual(s) have been mitigated.
 
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
Designation Statements

Interprofessional Continuing Education (IPCE)

This activity was planned by, and for, the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Nurses (CNE)

This activity is designated for 1.0 contact hours.

Pharmacists (CPE)

Vizient, Inc. designates this enduring material for a maximum of 1.0 contact hours for pharmacists.

Universal Activity Number: JA0006103-0000-26-147-H01-P

Pharmacy Technicians (CPE)

Vizient, Inc. designates this enduring material for a maximum of 1.0 contact hours for pharmacy technicians.

Universal Activity Number: JA0006103-0000-26-147-H01-T

International Accreditors for Continuing Education and Training (IACET)

Vizient, Inc. is Jointly Accredited by the Joint Accreditation for Interprofessional Continuing Education and has been approved to offer Continuing Education Units (CEUs). CEUs are awarded for learning events that align with the ANSI/IACET Standard for Continuing Education and Training. IACET is recognized internationally as a standards development organization and accrediting body that promotes quality continuing education and training.

This learning event is eligible for 0.1 Continuing Education Units (CEUs). 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 ANCC
  • 0.10 IACET
  • 1.00 Interprofessional Continuing Education (IPCE)
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity evaluation and to claim CE Credit.
 
Please Note: 
 
  • If the Register/Take Course tab is displayed instead of the Obtain Credit tab, you must first login to proceed with the credit claim process.
  • This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
  • Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code

 

 

Required Hardware/software

 

The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.